John Ransom
Stock Analyst at Raymond James
(4.61)
# 248
Out of 4,996 analysts
211
Total ratings
66.32%
Success rate
16.14%
Average return
Main Sectors:
Stocks Rated by John Ransom
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ACHC Acadia Healthcare Company | Downgrades: Outperform | $40 → $26 | $24.53 | +5.99% | 9 | Aug 14, 2025 | |
RDNT RadNet | Reiterates: Strong Buy | $66 → $75 | $75.91 | -1.20% | 12 | Aug 13, 2025 | |
AVAH Aveanna Healthcare Holdings | Upgrades: Outperform | $9 | $8.75 | +2.86% | 8 | Aug 11, 2025 | |
SCI Service Corporation International | Reiterates: Outperform | $85 → $90 | $82.11 | +9.61% | 13 | Aug 4, 2025 | |
THC Tenet Healthcare | Reiterates: Outperform | $185 → $200 | $202.00 | -0.99% | 18 | Jul 23, 2025 | |
CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $286.17 | +34.54% | 18 | May 5, 2025 | |
UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $344.08 | +56.94% | 13 | Apr 21, 2025 | |
HCA HCA Healthcare | Downgrades: Market Perform | n/a | $419.08 | - | 21 | Nov 22, 2024 | |
CYH Community Health Systems | Downgrades: Underperform | n/a | $3.18 | - | 8 | Nov 22, 2024 | |
GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.04 | +147.52% | 2 | May 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $85 → $95 | $126.70 | -25.02% | 15 | Apr 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $254.95 | - | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $18.42 | +8.58% | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $23.62 | +27.01% | 12 | Mar 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $17.53 | -31.55% | 9 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $75.77 | +12.18% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $117.34 | -10.52% | 8 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $7.42 | +34.77% | 4 | Aug 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.80 | - | 11 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $27.81 | - | 7 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $43.67 | - | 2 | Feb 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $29.14 | - | 2 | Dec 20, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $130.80 | - | 8 | Nov 7, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.84 | - | 2 | Aug 9, 2017 |
Acadia Healthcare Company
Aug 14, 2025
Downgrades: Outperform
Price Target: $40 → $26
Current: $24.53
Upside: +5.99%
RadNet
Aug 13, 2025
Reiterates: Strong Buy
Price Target: $66 → $75
Current: $75.91
Upside: -1.20%
Aveanna Healthcare Holdings
Aug 11, 2025
Upgrades: Outperform
Price Target: $9
Current: $8.75
Upside: +2.86%
Service Corporation International
Aug 4, 2025
Reiterates: Outperform
Price Target: $85 → $90
Current: $82.11
Upside: +9.61%
Tenet Healthcare
Jul 23, 2025
Reiterates: Outperform
Price Target: $185 → $200
Current: $202.00
Upside: -0.99%
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $286.17
Upside: +34.54%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $344.08
Upside: +56.94%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $419.08
Upside: -
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.18
Upside: -
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.04
Upside: +147.52%
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $126.70
Upside: -25.02%
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $254.95
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $18.42
Upside: +8.58%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $23.62
Upside: +27.01%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $17.53
Upside: -31.55%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $75.77
Upside: +12.18%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $117.34
Upside: -10.52%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $7.42
Upside: +34.77%
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $2.80
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $27.81
Upside: -
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $43.67
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $29.14
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $130.80
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $21.84
Upside: -